Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | No |
| Is net profit margin increasing? | No | Yes |
| Is asset turnover increasing? | No | Yes |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Demant A/S |
| Coloplast A/S |
| 2cureX AB (publ) |
| Ambu A/S |
| Cytosorbents Corporation |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| DEMANT | COLO B | 2CUREX | AMBU B | HQE1 | VIRO | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 31% | 27% | -175% | 6% | -96% | -126% | ||
| Fiscal Year - 1 | 32% | 37% | -51% | 3% | -99% | -73% | ||
| Fiscal Year - 2 | 28% | 57% | -28% | 2% | -67% | -59% | ||
| Fiscal Year - 3 | 33% | 62% | -17% | 8% | -35% | -74% | ||
| Fiscal Year - 4 | 14% | 59% | -38% | 11% | -19% | -51% | ||
| Fiscal Year - 5 | 20% | 58% | -43% | 16% | -189% | -36% | ||
| Average | 26% | 50% | -59% | 8% | -84% | -70% | ||
| Median | 29% | 58% | -40% | 7% | -82% | -66% | ||
| Benchmarks | Ticker | |||||||
| Demant A/S | CPSE:DEMANT | |||||||
| Coloplast A/S | CPSE:COLOB | |||||||
| 2cureX AB (publ) | OM:2CUREX | |||||||
| Ambu A/S | CPSE:AMBUB | |||||||
| Cytosorbents Corporation | DB:HQE1 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | DEMANT | COLO B | 2CUREX | AMBU B | HQE1 | VIRO | ||
| Latest Fiscal Year | Dec-24 | Sep-24 | Dec-23 | Sep-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Mar-25 | Jun-24 | Mar-25 | Mar-25 | Mar-25 | ||
| Revenues | ||||||||
| Latest Twelve Months | 22,419 | 27,794 | 2 | 5,834 | 35 | 7 | ||
| Fiscal Year | 22,419 | 27,030 | 3 | 5,391 | 36 | 7 | ||
| Fiscal Year - 1 | 21,601 | 24,500 | 3 | 4,775 | 31 | 7 | ||
| Fiscal Year - 2 | 19,705 | 22,579 | 7 | 4,444 | 35 | 15 | ||
| Fiscal Year - 3 | 17,905 | 19,426 | 15 | 4,013 | 43 | 8 | ||
| Fiscal Year - 4 | 14,469 | 18,544 | 12 | 3,567 | 41 | 5 | ||
| Fiscal Year - 5 | 14,946 | 17,939 | 8 | 2,820 | 25 | 4 | ||
| Net Income | ||||||||
| Latest Twelve Months | 2,891 | 4,544 | (26) | 370 | (16) | (14) | ||
| Fiscal Year | 2,891 | 5,052 | (33) | 235 | (21) | (14) | ||
| Fiscal Year - 1 | 2,820 | 4,783 | (30) | 168 | (29) | (12) | ||
| Fiscal Year - 2 | 2,274 | 4,706 | (19) | 93 | (33) | (10) | ||
| Fiscal Year - 3 | 2,696 | 4,825 | (7) | 247 | (25) | (18) | ||
| Fiscal Year - 4 | 1,121 | 4,197 | (8) | 241 | (8) | (19) | ||
| Fiscal Year - 5 | 1,462 | 3,873 | (7) | 317 | (19) | (19) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 30,546 | 48,140 | 30 | 7,061 | 47 | 20 | ||
| Latest Fiscal Quarter | 32,450 | 49,152 | 7 | 7,414 | 51 | 16 | ||
| Fiscal Year | 32,450 | 48,073 | 16 | 7,154 | 47 | 18 | ||
| Fiscal Year - 1 | 30,546 | 48,159 | 48 | 6,859 | 53 | 25 | ||
| Fiscal Year - 2 | 29,857 | 37,446 | 79 | 7,215 | 63 | 18 | ||
| Fiscal Year - 3 | 24,860 | 15,841 | 63 | 5,740 | 90 | 20 | ||
| Fiscal Year - 4 | 21,927 | 13,499 | 38 | 4,926 | 90 | 38 | ||
| Fiscal Year - 5 | 21,798 | 12,732 | 24 | 4,558 | 27 | 45 | ||
| Fiscal Year - 6 | 17,935 | 11,769 | 23 | 4,234 | 34 | 63 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 9,256 | 16,200 | 27 | 5,605 | 19 | 13 | ||
| Latest Fiscal Quarter | 9,564 | 16,942 | 3 | 5,914 | 15 | 8 | ||
| Fiscal Year | 9,564 | 17,942 | 12 | 5,594 | 11 | 11 | ||
| Fiscal Year - 1 | 9,256 | 17,299 | 43 | 5,393 | 23 | 17 | ||
| Fiscal Year - 2 | 8,561 | 8,292 | 74 | 4,261 | 35 | 16 | ||
| Fiscal Year - 3 | 7,977 | 8,168 | 59 | 3,952 | 63 | 16 | ||
| Fiscal Year - 4 | 8,250 | 7,406 | 28 | 2,372 | 79 | 31 | ||
| Fiscal Year - 5 | 7,636 | 6,913 | 14 | 2,182 | 3 | 42 | ||
| Fiscal Year - 6 | 7,050 | 6,418 | 20 | 1,882 | 17 | 61 | ||